By Amy Banks
Welcony Introduces the Next Evolution in TMS Research – The New Magstim Rapid TMS System Innovation never stands still at Magstim, and neither should your research or TMS therapy. That’s why Magstim, a Welcony brand is proud to announce the release of the New Magstim Rapid TMS System. The new Magstim Rapid represents a significant … Continued
By Amy Banks
Magstim Passes Compliance with Strict European Union Medical Device Regulations Expanding Magstim Access to Entire EU Marketplace CARMARTHENSHIRE, United Kingdom – (MAY 16, 2025) – Magstim has been granted EU MDR Certification for all transcranial magnetic stimulation (TMS) systems, demonstrating compliance with strict European Union Medical Device Regulations. This provides a path for Magstim TMS … Continued
By Amy Banks
Magstim Horizon Inspire and 3.0 Transcranial Magnetic Stimulation Systems have received FDA clearance for the treatment of Major Depressive Disorder (MDD) in adolescent patients, ages 15-21. This represents a major advancement in mental health care, introducing new opportunities for effective, non-invasive treatments designed specifically for younger patients struggling with depression. To read the full article … Continued
By Amy Banks
Exciting Magstim News – Magstim TMS Cited in Science Robotics In the latest edition of Science Robotics (January 2025), the study, “Surmounting the Ceiling Effect of Motor Expertise by Novel Sensory Experience with a Hand Exoskeleton”, highlights research using a Magstim 2002 Transcranial Magnetic Stimulation (TMS) stimulator whilst enhancing the neural adaptability of participants as they interacted with a state-of-the-art hand … Continued
By Amy Banks
By Amy Banks